Red Hat (RHAT) Quote

Amen

Great post here..

The NDA is basically crafted - the eCTD was agreed upon by the International Committee on Harmonization so that any regulatory agency anywhere will accept the same document with only minor changes.

NLSP............................................https://stockcharts.com/h-sc/ui?s=NLSP&p=W&b=5&g=0&id=p86431144783

Trump is Toast.
America’s saviors.
https://youtu.be/lR1rxxIYa-w

$ILLR Turning Triller's hidden gems into the ultimate next-gen entertainment platform! 💥
Triller is a game-changer in the world of digital content. 🌐
https://trillercorp.com/exciting-opportunity-to-leverage-trillers-underutilized-assetsto-create-next-gen-entertainment-p

$ILLR Turning Triller's hidden gems into the ultimate next-gen entertainment platform! 💥
Triller is a game-changer in the world of digital content. 🌐
https://trillercorp.com/exciting-opportunity-to-leverage-trillers-underutilized-assetsto-create-next-gen-entertainment-p

STAF $3.97 + 140%

"Only time will tell if this is legit and what it can do"


If this was not legit how do you explain a company like Dell,multi billion dollars market cap, showing for over two years on their web site that OneMind is an Edge Partener. They name OneMind specifically. I hardly think De

Lol. They are not false. I always Iiked you Curt. You were always more reserved and respectful than others. I guess it just coincidence for the last 6-7 years you always show up on the same plays with this crew right? It’s not rocket science. Have a good day.

STAF it back up 100%

$VKTX 75'S -16% off highs

First question that comes to mind: do they pay for using those images? More like a rhetorical question, I guess.

plby.....acrs........yygh.......gsat....................................https://www.stockscores.com/charts/charts/?ticker=PLBY

the 73 coauthors actually did point out the absence of individual patient data which is the discussion here

You were so convinced this was moving up to your top shelf.

They (especially Girsky) said a lot more after the Q2 results , explaining their approach to national accounts to get the committed volumes so they can negotiate with the supplier to get realistic volume pricing. Especially for expensive items not just the Fuel cell but wiring and radiators (which

I think shareholders should be questioning if whether the chairman is acting in the best fudiciary duty to gncp shareholders

Brother, give all the investment advice you like, but spend enough time with lawyers and you likely won't.

100% agree
First was the fda required it and second was crossover was needed to get people to join the trial as no one wants to be the control.
therefore I suspect the SurVaxM will have a lot of trouble finding patients willing to die so they can be compared with the treatment arm

~ ASPI $7.81 With 8k confirmation...


[aspi_8k.htm](http://archive.fast-edgar.com/20241104/A6ZZBG2CZ22FKZQX222R2ZZ2G5MDZZ28Z962/)

CTM.......GRI......NUWE.........HRYU........,,,,,,,,,,,,,,,,,,,,,,,,,,,p/m

Well equally Blarcamesine (pooled) had 5.4% with falls vs placebo who had 11.9% with falls meaning falls were reduced 55% when Blarcamesine was involved. Or put another way placebo group had more than double the % number of falls as Blarca.
Considering you and the market have not made much of